Pharmacists at St. Jude Children’s Research Hospital in Memphis, Tenn., have started using 3D-printing technology to help produce compounded medications starting with hydrocortisone formulations.
The hospital is working to integrate the printers within existing U.S. Pharmacopoeia standards for nonsterile and hazardous drug compounding, according to a Sept. 11 news release from the American Society of Health-System Pharmacists.
Hospital pharmacists said the approach has the potential to improve medication precision and adherence for patients who need customized doses, especially in pediatrics and geriatrics.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
